Erin Kathleen Marasco

This inventor holds 9 USPTO granted patents and 8 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignees: Cargill Inc., Basf Enzymes LLC, Verenium Corporation. Active years: 2014-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Erin Kathleen Marasco. Retrieved from https://idiyas.com/inventor/erin-kathleen-marasco

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 9 (Patent Applications = 8)

% Patents Active = 77.8

CIPO Patents = 2 (Patent Applications = 4)

EPO Patents = 2 (Patent Applications = 8)

Average Co-Inventor Count = 5.9

ph-index = 1

Forward Citations = 2(Granted Patents)

Location History:

Minneapolis, MN (US) (2014)
Plymouth, MN (US) (2022)
Excelsior, MN (US) (2016 - 2023)

Company Filing History:

Years Active: 2014-2024

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12134764 - Genetically modified haploid (2024-11-05),

2. 12123045 - Genetically modified cells that produce C6-C10 fatty acid derivatives (2024-10-22),

3. 11737474 - Protein concentrates from oil seeds and methods of producing the same (2023-08-29),

4. 11718820 - Genetically modified haploid (2023-08-08),

5. 11345938 - Genetically modified cells that produce C6-C10 fatty acid derivatives (2022-05-31),

6. 10844363 - Xylose isomerase-modified yeast strains and methods for bioproduct production (2020-11-24),

7. 9399763 - Transferases and oxidoreductases, nucleic acids encoding them and methods for making and using them (2016-07-26),

8. 8785162 - Aminotransferase and oxidoreductase nucleic acids and polypeptides and methods of using (2014-07-22),

9. 8709772 - Transferases and oxidoreductases, nucleic acids encoding them and methods for making and using them (2014-04-29),

Title: The Innovative Contributions of Erin Kathleen Marasco

Introduction

Erin Kathleen Marasco is a prominent inventor based in Excelsior, MN (US). She has made significant strides in the field of biotechnology, holding a total of 9 patents. Her work primarily focuses on genetically modified organisms and their applications in fermentation processes.

Latest Patents

One of her latest patents involves genetically modified haploid cells. These less-than-diploid cells are produced with at least one unpaired chromosome, making them useful fermentation strains. They perform similarly to diploid strains that are engineered in comparable ways. Additionally, these less-than-diploid strains can be mated to produce diploids, which are also beneficial as fermentation strains. Another notable patent pertains to genetically modified cells that produce C6-C10 fatty acid derivatives. By introducing genes encoding mutant 3-ketoacyl-CoA synthases into host cells, Erin's innovations enhance the production of shorter-chain fatty acids and derivatives, improving productivity significantly.

Career Highlights

Throughout her career, Erin has worked with notable companies such as Cargill Inc. and BASF Enzymes LLC. Her contributions to these organizations have been instrumental in advancing their research and development efforts in biotechnology.

Collaborations

Erin has collaborated with several professionals in her field, including Ana Negrete-Raymond and David Paul Weiner. These partnerships have fostered innovation and have led to the successful development of her patented technologies.

Conclusion

Erin Kathleen Marasco's work exemplifies the impact of innovative thinking in biotechnology. Her patents and collaborations continue to influence the industry, paving the way for future advancements.

Profile summary based on public USPTO records.